HMD (continued) just to complete the picture for anyone new to...

HMD (continued) just to complete the picture for anyone new to HMD one of the reasons long time followers are so excited about the potential is the AI ORION platform in addition to the herabeat device itself. I have held since FDA approval BTW despite increasing my holding in last few weeks.

David CEO is an alumni of MASRAM the elite Israel defence force computing centre of excellence. His vision and design for Heramed extends beyond medical grade monitoring at home to an AI platform which gives better deductions and predictive ability than a practitioner whether at home or in the clinic.

The partnership with the Mayo clinic is an amazing opportunity to be the world first and best at this due to the years of datasets they have access to to finetune the AI algorithms.

AI driven medical diagnostics is the future of medicine as removes human error or compliments a practitioner by highlighting risk factors earlier.

what’s particularly interesting about the point in time for HMD is all the current partnerships (multiple as highlighted) are based on the Heramed device usage on its own. Their website describes ORION as ‘in stealth mode’. You will see from the latest update it’s first release and clinical trials are going to happen within months (qtr 4 this year). These will be seperate clinical trials to the ones currently in WA for example which are assessing the accuracy of the Heramed device on its own.

if they successfully prove the ORION AI platform makes effective calls which reduce the risk to mother and child the acceleration factor when paired with Herabeat will be huge. Clinics could adopt ORION as its own seperate value proposition which would open the door to Herabeat and visa versa the existing partnerships based on trialing Herabeat will be an open door to take ORION back to the clinic.

DYOR